I  venVelo

http://www.venvelo.com/





     Office Locations:

270 West New England Ave
Winter Park, FL 32789

 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Media & Digital Media
  • Software & Internet

  •  

    Description:

    Founded in 2012, venVelo is a venture fund and business accelerator focused on early-stage opportunities. The firm prefers to invest in technology companies located or based out of Florida. VenVelo closed its most recent funding round at $1.3 million.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Allen H. Kupetz COO and Vice President
    Pat McNair CFO and Vice President
    Peter McAlindon Ph.D Chief Community Relations Officer
    Richard Licursi CEO and President

     

    Portfolio companies include:


      flexReceipts
        web link


      Genicon
        web link


      Kairos
        web link


      Mcast Networks
        web link


      Spectrum Bridge
        web link


      Splyt
        web link


      Thrive
        web link


      Vigilant Biosciences
        web link


      Zentila
        web link


     

    Recent News: